fumarates and Multiple-Sclerosis--Chronic-Progressive

fumarates has been researched along with Multiple-Sclerosis--Chronic-Progressive* in 2 studies

Reviews

1 review(s) available for fumarates and Multiple-Sclerosis--Chronic-Progressive

Article	Year
Diroximel Fumarate in Relapsing Forms of Multiple Sclerosis: A Profile of Its Use. CNS drugs, 2021, Volume: 35, Issue:6 Diroximel fumarate (Vumerity Topics: Administration, Oral; Adult; Animals; Dimethyl Fumarate; Fumarates; Humans; Immunosuppressive Agents; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Therapeutic Equivalency	2021

Other Studies

1 other study(ies) available for fumarates and Multiple-Sclerosis--Chronic-Progressive

Article	Year
Nrf2 and beyond: deciphering the mode of action of fumarates in the inflamed central nervous system. Acta neuropathologica, 2015, Volume: 130, Issue:2 Topics: Animals; Brain; Encephalomyelitis, Autoimmune, Experimental; Female; Fumarates; Humans; Male; Microglia; Multiple Sclerosis, Chronic Progressive; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oligodendroglia; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Synapses	2015

Article

Year

Nrf2 and beyond: deciphering the mode of action of fumarates in the inflamed central nervous system.

Acta neuropathologica, 2015, Volume: 130, Issue:2

Topics: Animals; Brain; Encephalomyelitis, Autoimmune, Experimental; Female; Fumarates; Humans; Male; Microglia; Multiple Sclerosis, Chronic Progressive; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oligodendroglia; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Synapses

2015